These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Assessment of teratogenic potential of therapeutic agents: preclinical toxicology. Frederick GL Clin Invest Med; 1985; 8(4):323-7. PubMed ID: 4075617 [TBL] [Abstract][Full Text] [Related]
4. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents). Brent RL Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop. Lai DY; Baetcke KP; Vu VT; Cotruvo JA; Eustis SL Regul Toxicol Pharmacol; 1994 Apr; 19(2):183-201. PubMed ID: 8041916 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic kits in parasitology: which controls?]. Rossi P Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705 [TBL] [Abstract][Full Text] [Related]
7. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
8. Speculations on the rodent carcinogenicity of 30 chemicals currently under evaluation in rat and mouse bioassays organised by the U.S. National Toxicology Program. Bootman J Environ Mol Mutagen; 1996; 27(3):237-43. PubMed ID: 8625960 [TBL] [Abstract][Full Text] [Related]
9. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status. Box RJ; Spielmann H Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470 [TBL] [Abstract][Full Text] [Related]
10. [Models and methods used for the selection of antitumor preparations in the USSR and abroad]. Sof'ina ZP Vopr Onkol; 1976; 22(4):82-96. PubMed ID: 1274284 [No Abstract] [Full Text] [Related]
11. The preclinical new drug research program of the National Cancer Institute. Driscoll JS Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438 [TBL] [Abstract][Full Text] [Related]
12. Collaborative Behavioral Teratology Study: protocol design and testing procedures. Adams J; Buelke-Sam J; Kimmel CA; Nelson CJ; Reiter LW; Sobotka TJ; Tilson HA; Nelson BK Neurobehav Toxicol Teratol; 1985; 7(6):579-86. PubMed ID: 3835452 [TBL] [Abstract][Full Text] [Related]
13. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
14. Behavioral methods in reproductive and developmental toxicology. Chester A; Hallesy D; Andrew F Neurobehav Toxicol Teratol; 1985; 7(6):745-52. PubMed ID: 3835476 [TBL] [Abstract][Full Text] [Related]
15. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
16. Regulatory aspects of teratology: role of the Food and Drug Administration. Kelsey FO Teratology; 1982 Apr; 25(2):193-9. PubMed ID: 7048616 [TBL] [Abstract][Full Text] [Related]
17. [Soviet-American cooperation in experimental and clinical chemotherapy from 1972 to 1979]. Peredovchikova NI; Kiselev AV; Puchkov IuI; Komarova LE; Gorbunova VA Vopr Onkol; 1980; 26(12):3-6. PubMed ID: 7008350 [No Abstract] [Full Text] [Related]
18. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages. Brent RL Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806 [TBL] [Abstract][Full Text] [Related]
19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
20. The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary. Venditti JM Cancer Treat Rep; 1983 Sep; 67(9):767-72. PubMed ID: 6883352 [No Abstract] [Full Text] [Related] [Next] [New Search]